123343-99-7Relevant articles and documents
AMINOPYRAZOLE DERIVATIVES
-
Paragraph 0257; 0258, (2018/05/03)
An objective of the present invention is to provide low-molecular-weight compounds that can inhibit Src family kinases. The present invention relates to compounds represented by general formula (I) or pharmacologically acceptable salts thereof. In the formula, Ar1 is optionally substituted C6-10 arylene or 5- to 10-membered heteroarylene, and Ar2 is optionally substituted C6-10 aryl or 5- to 10-membered heteroaryl. R1 and R2 are defined as described in the specification.
5-aminoacetylaminosulfonanilide compounds
-
, (2008/06/13)
The present compounds represented by the formula: STR1 (wherein R1 is a phenyl group, a halophenyl group or a cycloalkyl group having 3 to 8 carbon atoms, R2 is a hydrogen atom or an alkyl group having 1 to 5 carbon atoms, R3 is a hydrogen atom, an alkyl group having 1 to 7 carbon atoms, a cycloalkyl group having 3 to 8 carbon atoms, an alkenyl group having 3 to 5 carbon atoms or a benzyl group, or R2 and R3 are bonded together to form a 5- to 7-membered heterocycle) and salts thereof have potent anti-inflammatory, antipyretic, analgesic and anti-allergic actions with less side effects such as gastrointestinal disorders and with such a high safety as to permit long-term administration.
5-aminosulfonanilide compounds
-
, (2008/06/13)
5-Aminosulfonanilide compounds represented by the formula: STR1 (wherein R is a hydrogen atom, a formyl group, an acetyl group, a propionyl group, an n-butyryl group, an n-valeryl group, an ethoxyoxalyl group, an n-propoxyoxalyl group, a methoxycarbonylac